# Baxter Healthcare Corporation - Inspection Records

Source: https://www.keypedia.com/companies/baxter-healthcare-corporation/19a30564-2115-4586-a055-e1b5efcf06ee

> Inspection records and compliance data for Baxter Healthcare Corporation in Marion, North Carolina. Access full analysis and detailed observations.

---

## Details

- Name: Baxter Healthcare Corporation
- FEI Number: 1025114
- City: Marion
- State: North Carolina
- Country Name: United States
- Address Line 1: 65 Pitts Station Rd
- Zip Code: 28752
- Business Operations: API MANUFACTURE, FDF MANUFACTURE

## Related Documents

- [483 - Baxter Healthcare Corporation - 2024-02-09](https://www.keypedia.com/records/483/baxter-healthcare-corporation/17d95756-c80b-494c-958b-dbcc9e7dbc61) — source: FDA, date: February 9, 2024
- [FDA Inspection 1230544 - Baxter Healthcare Corporation - 2024-02-09](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/af306a83-c8f6-4639-8e6c-5d8b74cc7791) — classification: Official Action Indicated (OAI), source: FDA, date: February 9, 2024
- [483 - Baxter Healthcare Corporation - 2023-10-31](https://www.keypedia.com/records/483/baxter-healthcare-corporation/446afdff-a64c-415f-b38e-b41265c73e19) — source: FDA, date: October 31, 2023
- [FDA Inspection 1221559 - Baxter Healthcare Corporation - 2023-10-31](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/e56f6b7d-ffa0-4a4e-b741-2e06fe829dff) — classification: Official Action Indicated (OAI), source: FDA, date: October 31, 2023
- [FDA Inspection 1169330 - Baxter Healthcare Corporation - 2022-05-12](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/606d68ba-1323-4d69-9029-1cd53688f34e) — classification: No Action Indicated (NAI), source: FDA, date: May 12, 2022
- [FDA Inspection 1169330 - Baxter Healthcare Corporation - 2022-05-12](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/ce5076b5-1e62-4a8e-b708-c17c96eee53e) — classification: Official Action Indicated (OAI), source: FDA, date: May 12, 2022
- [FDA Inspection 1151566 - Baxter Healthcare Corporation - 2021-07-01](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/6f6646e5-02d3-4664-9b0c-77f2e594755a) — classification: No Action Indicated (NAI), source: FDA, date: July 1, 2021
- [FDA Inspection 1031655 - Baxter Healthcare Corporation - 2017-11-17](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/c70d8cf6-ee98-4a1e-9d34-422e372ef98d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 17, 2017
- [FDA Inspection 969544 - Baxter Healthcare Corporation - 2016-02-26](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/637c2017-17ca-4e10-95d5-86f313665224) — classification: Official Action Indicated (OAI), source: FDA, date: February 26, 2016
- [FDA Inspection 864887 - Baxter Healthcare Corporation - 2014-01-24](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/527bf48d-d520-46d3-a2d5-29d6f3cb8a3d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 24, 2014
- [FDA Inspection 808425 - Baxter Healthcare Corporation - 2012-11-16](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/c40fbc45-11cb-4752-955d-2910463fcff8) — classification: Official Action Indicated (OAI), source: FDA, date: November 16, 2012
- [FDA Inspection 808425 - Baxter Healthcare Corporation - 2012-11-16](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/6250880b-774f-455b-8c66-aa58bd33705f) — classification: Official Action Indicated (OAI), source: FDA, date: November 16, 2012

## Related Companies

- [Zoetis Belgium S.A.](https://www.keypedia.com/companies/zoetis-belgium-sa/b21b52a1-7a14-464f-aab2-c3d558f53879)
- [ONY Biotech, Inc.](https://www.keypedia.com/companies/ony-biotech-inc/a2997e30-1b39-4dea-9fec-a960aafcefd0)
- [Valdepharm](https://www.keypedia.com/companies/valdepharm/9a1bab54-2984-4dec-8384-e3aaa423bda7)
- [GlaxoSmithKline Manufacturing S.p.A.](https://www.keypedia.com/companies/glaxosmithkline-manufacturing-spa/11f7427f-c02e-4b80-91dd-f90cbe9b90a9)
- [Hainan Shuangcheng Pharmaceuticals Co Ltd](https://www.keypedia.com/companies/hainan-shuangcheng-pharmaceuticals-co-ltd/920c7235-0cdd-4c0a-884c-43e1f605c1c6)
- [Shandong New Time Pharmaceutical Co. Ltd.](https://www.keypedia.com/companies/shandong-new-time-pharmaceutical-co-ltd/470fe860-121a-4594-b9a5-e6bf05ce1926)
- [N.V. Organon (MSD)](https://www.keypedia.com/companies/nv-organon-msd/dc305126-e2d1-4dba-8538-f815391f40a5)
- [Zoetis Manufacturing & Research Spain, S.L.](https://www.keypedia.com/companies/zoetis-manufacturing-research-spain-sl/c6438237-5a22-44d1-8ea5-a466eee486b2)
- [Xellia Pharmaceuticals ApS](https://www.keypedia.com/companies/xellia-pharmaceuticals-aps/5d9704ca-114e-4a65-abca-966a5c4e2a57)
- [Bio-Technology General (Israel), Ltd.](https://www.keypedia.com/companies/bio-technology-general-israel-ltd/7e4f2eb9-bacb-4307-9003-5a223c16eed8)

## Related Officers

- [Scott T. Ballard](https://www.keypedia.com/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da)
- [Christopher J. Adams](https://www.keypedia.com/people/christopher-j-adams/f7010846-7fd1-4ee8-901a-1015656fea0a)
- [Fabia M Lugo](https://www.keypedia.com/people/fabia-m-lugo/336ff45f-5188-42f6-91cd-3b60931c0602)
- [Pharmaceutical Specialist/ Investigator ](https://www.keypedia.com/people/veronica-fuentes/50ea657f-39e6-4d97-a627-86339df3fbe6)